Why the study?
The association between minimum invasive central venous pressure within the first 24 hours after ICU admission following cardiopulmonary bypass and 30-day postoperative outcomes was evaluated.
Does elevated minimum central venous pressure (≥ 10 mmHg) within 24 hours post-ICU admission increase 30-day mortality in patients undergoing cardiac surgery with cardiopulmonary bypass?
Does elevated minimum central venous pressure (≥ 10 mmHg) within 24 hours post-ICU admission increase 30-day mortality in patients undergoing cardiac surgery with cardiopulmonary bypass?
Early postoperative minimum CVP ≥ 10 mmHg is strongly associated with increased 30-day mortality after cardiopulmonary bypass and may serve as a risk-stratification marker.
Elevated min CVP ≥10 mmHg early post-CPB was associated with higher 30-day mortality; supports hypothesis-generating risk stratification but should not yet change practice.
Objective To evaluate the association between the minimum invasive central venous pressure (CVP) recorded within the first 24 h after intensive care unit (ICU) admission following cardiopulmonary bypass (CPB) and 30‐day postoperative outcomes. Methods A total of 3348 patients undergoing cardiac surgery who required CPB were selected from the Medical Information Mart for Intensive Care III (MIMIC‐III) database. Based on the minimum valid invasive CVP value recorded within the first 24 h after ICU admission following CPB, patients were divided into three groups: ≤ 5 mmHg, 6–9 mmHg, and ≥ 10 mmHg ( n = 2018, 1018, and 312, respectively). The perioperative characteristics among the three groups were compared. The log‐rank test was used to explore the differences in survival rates among various CVP groups, and the Cox regression analysis was employed to explore the effect of different CVP levels on a 30‐day mortality. Results In unadjusted analysis, CVP ≥ 10 mmHg was strongly associated with an increased 30‐day mortality compared with CVP ≤ 5 mmHg ([hazard ratio, HR] = 8.07, 95% CI: 4.92–13.25). After sequential adjustment for disease severity scores, laboratory indices, and intraoperative variables, this association was attenuated but remained statistically significant in the fully adjusted model (HR = 3.34, 95% [confidence interval, CI]: 1.77–6.32, p < 0.001). In contrast, CVP 6–9 mmHg was not significantly associated with a 30‐day mortality compared with CVP ≤ 5 mmHg (fully adjusted HR = 1.12, 95% CI: 0.61–2.04). The 30‐day mortality rates were 1.44%, 2.06%, and 10.90% in the CVP ≤ 5 mmHg, CVP 6–9 mmHg, and CVP ≥ 10 mmHg groups, respectively. Conclusion CVP ≥ 10 mmHg was strongly associated with an increased 30‐day mortality in unadjusted analysis, and this association persisted after full adjustment, although the effect size was attenuated. CVP 6–9 mmHg was not significantly associated with mortality compared with CVP ≤ 5 mmHg. Early postoperative minimum CVP may serve as a risk‐stratification marker, but causal relationships cannot be inferred from this observational study.
No takes yet. Share an insight, caveat, or question.
Gao et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: